Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10287266 Compounds and compositions for inhibiting the activity of SHP2

Patent 10287266 was granted and assigned to Novartis on May, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Novartis

Current Assignee

Novartis

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

102872660

Patent Inventor Names

Bakary-Barry Toure0

Patrick James Sarver0

Rajesh Karki0

Zhuoliang Chen0

Andriana Jouk0

Bing Yu0

Gang Liu0

Jorge Garcia Fortanet0

...

Date of Patent

May 14, 2019

Patent Application Number

157369250

Date Filed

June 15, 2016

Patent Citations Received

‌

US Patent 10988466 Heterocyclic derivatives useful as SHP2 inhibitors

‌

US Patent 10858359 Heterocyclic ring derivatives useful as SHP2 inhibitors

Patent Primary Examiner

‌

Shawquia Jackson

Patent abstract

The present invention relates to compounds of formula I:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10287266 Compounds and compositions for inhibiting the activity of SHP2

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API